United Therapeutics (UTHR) Shares Edge Higher as Wedbush Upgrades to Outperform
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $499.73 -0.31%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Shares of United Therapeutics Corp. (NASDAQ: UTHR) have ticked higher in intraday action as an analyst at Wedbush just upgraded the stock from Neutral to Outperform. The firm also boosted its price target from $79 to $94.
Traders in UTHR shares are responding to Q1 results from the company Thursday morning.
With the stock last trading at $68.92 (down 2.5 percent from Wednesday's close), Wedbush's new price target suggests potential upside of about 36 percent.
For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.
Traders in UTHR shares are responding to Q1 results from the company Thursday morning.
With the stock last trading at $68.92 (down 2.5 percent from Wednesday's close), Wedbush's new price target suggests potential upside of about 36 percent.
For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Diana Shipping withdraws bid to acquire Genco Shipping
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
UpgradesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
